title: Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
abstract: There has been substantial progress in preventing and treating CMV infection. Prophylaxis with CMV screened blood products, IVIG and antiviral drugs (high dose acyclovir and/or Ganciclovir) considerably reduce the incidence of CMV disease and nearly eliminate CMV pneumonia after allogeneic BMT.
authors.affiliation: Service de Greffe de Moelle, Hôpital Saint Louis, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Devergie
authors.forename: R
authors.initials: R
authors.lastname: Traineau
authors.forename: H
authors.initials: H
authors.lastname: Esperou-Bourdeau
authors.forename: P
authors.initials: P
authors.lastname: Ribaud
authors.forename: G
authors.initials: G
authors.lastname: Socié
authors.forename: P
authors.initials: P
authors.lastname: Richard
authors.forename: F
authors.initials: F
authors.lastname: Selimi
authors.forename: I
authors.initials: I
authors.lastname: Hirsch
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D014184:Transplantation, Homologous
chemical_list: D000914:Antibodies, Viral